GLP-1 and amylin receptor multiagonism with amycretin for obesity management. Khoo B, Tan TM. Lancet 2025 Jun 20:S0140-6736(25)01250-4. doi: 10.1016/S0140-6736(25)01250.

Read + Share

Amedeo Smart

Independent Medical Education

Khoo B, Tan TM. GLP-1 and amylin receptor multiagonism with amycretin for obesity management. Lancet 2025 Jun 20:S0140-6736(25)01250-4. doi: 10.1016/S0140-6736(25)01250.
PMID: 40550232